Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Patent Granted And Revoked: Indian Patent Office Flip-Flop On Humira Worries Patent Experts

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Drug maker Abbott is caught in a peculiar situation over its Humira (adalimumab) patent in India. The Indian Patent Office is reported to have granted a patent for the blockbuster drug used in the treatment of rheumatoid arthritis but then unilaterally moved to revoke it just a month later



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts